From the AGM presentation:
Strong news flow for 2013 onwards….
• Ongoing communication
• Regular updates
Strong News Flow
Clinical development of TPM/oxycodone Q2/2013 ?
Clinical development of TPM/oxymorphone Q2/2013 ?
Expansion of TPM/diclofenac program with Nippon Zoki
(Japan)H2 /2013 ?
Strategic partnership for TPM Mastitis Project - USDA Q2/2013 ?
Novartis -Expansion of strategic partnership for
TPM/diclofenac Q2/2013 ?
Phase 2 TPM/retinoic acid (dermatology) Q3/2013
Phase 2 TPM/ketocanozole (dermatology) Q4/2013
Phase 2 TPM/oxycodone topical assessment Q3/2014
So based on that, they are not out of order. However, there is plenty more that needs explanation!
good story badly told.., page-81
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 64 | 103305097 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 22478912 | 7 |
View Market Depth
| Last trade - 16.12pm 05/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable